MedMen Enterprises, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the MedMen Enterprises, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, MedMen Enterprises, Inc. has logged 27 reports. The latest transaction was disclosed on 4 October 2023 (Attribution). Among the most active insiders: SMITH CAMERON DOVI. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 October 2023
All Executives27 Thresholds0 Prospectus0 Other0
Declarations 27 total
◆ CAO · Executives · 25 Sept 2023
5,102,041 shares 0Class B Subordinate Voting Shares SEC:0001209191-23-052087:0
◆ CFO · Executives · 24 Jul 2023
13,157,895 shares @ US$0.0228 100.0% of flow Class B Subordinate Voting Shares SEC:0001209191-23-043314:0
◆ Director · Executives · 19 Apr 2022
143,449 shares 0Class B Subordinate Voting Shares SEC:0001209191-22-050794:0
◆ Director · Executives · 19 Apr 2022
106,028 shares 0Class B Subordinate Voting Shares SEC:0001209191-22-050796:0
◆ Director · Executives · 19 Apr 2022
143,449 shares 0Class B Subordinate Voting Shares SEC:0001209191-22-050792:0
◆ Director · Executives · 19 Apr 2022
143,449 shares 0Class B Subordinate Voting Shares SEC:0001209191-22-050798:0
◆ Director · Executives · 19 Apr 2022
160,775 shares 0Class B Subordinate Voting Shares SEC:0001209191-22-050790:0
◆ Director · Executives · 9 Dec 2021
143,499 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-069204:0
◆ Director · Executives · 9 Dec 2021
14,924 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-069198:0
◆ Director · Executives · 9 Dec 2021
14,924 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-069200:0
◆ Director · Executives · 9 Dec 2021
160,824 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-069195:0
◆ Director · Executives · 9 Dec 2021
143,499 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-069202:0
◆ Interim COO · Executives · 14 Feb 2021
1,258,322 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059693:0
◆ Director · Executives · 3 May 2021
55,147 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059685:0
◆ Interim CFO · Executives · 29 Aug 2021
454,129 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059712:0
◆ Chief Revenue Officer · Executives · 29 Aug 2021
477,417 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059708:0
◆ CIO · Executives · 29 Aug 2021
781,809 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059702:0
◆ Director · Executives · 3 May 2021
55,147 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059680:0
◆ CEO · Executives · 14 Feb 2021
1,258,322 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-059721:0
9,813,234 shares Class B Subordinate Voting Shares SEC:0001209191-21-057752:0
◆ Director · Executives · 27 Aug 2021
286,998 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-055093:0
◆ Director · Executives · 27 Aug 2021
286,998 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-055083:0
◆ Director · Executives · 27 Aug 2021
286,998 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-055091:0
◆ Director · Executives · 27 Aug 2021
286,998 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-055089:0
◆ Director · Executives · 27 Aug 2021
307,423 shares 0Class B Subordinate Voting Shares SEC:0001209191-21-055086:0
25 of 27 declarations
Load more (2 remaining) 关于 MedMen Enterprises, Inc. MedMen Enterprises, Inc. 是一家美国大麻零售公司,其核心业务是高端药房概念和面向消费者的品牌定位。该公司与 MMNFF 股票代码相关联,尽管投资者可能将其大致归入更广泛的纽约证券交易所/纳斯达克市场,但其最近的市场现实更多地由合规、报告和监管问题而非正常的上市公司执行所定义。MedMen 成立于 2010 年,并以其在合法大麻零售领域中更具辨识度的品牌之一而闻名,强调精致的门店体验、产品教育以及为休闲客户和(在适用情况下)以健康为导向的用户提供便利。其总部和运营地址位于美国加利福尼亚州洛杉矶。
在运营方面,MedMen 专注于大麻零售和相关消费产品。其门店模式历来包括花卉、预卷、电子烟、食用产品、外用产品和其他以健康为导向的产品,公司将自己定位为一家精选的、高接触的零售商,而非商品销售商。MedMen 还强调全渠道功能,例如在线浏览、店内取货和在选定市场的配送服务。该公司表示提供广泛的产品种类和引导式购物体验,这在其品牌差异化中至关重要,因为在这个行业中,客户体验和监管许可往往与产品广度同样重要。
从竞争角度来看,MedMen 致力于成为美国合法大麻行业的旗舰零售品牌,而不仅仅是后台运营商。其公开宣传的业务范围集中在洛杉矶地区,包括西好莱坞、洛杉矶市中心和洛杉矶国际机场,早期的披露还表明在内华达州、伊利诺伊州、亚利桑那州、马萨诸塞州、佛罗里达州和纽约州等其他州也有业务。对于股权投资者而言,这种地域分布必须通过许可复杂性、各州法规和资本密集度来审视,所有这些都是美国大麻运营商面临的结构性挑战。
最近的事态发展尤为重要且大多不利。2025 年和 2026 年的 SEC 材料指出行政执法活动、逾期备案以及 2026 年撤销《交易法》注册。实际上,这大大降低了标准公开市场分析的有用性,因为披露质量和交易透明度已经减弱。因此,该公司最近的公开记录表明,其状况主要受监管和合规风险而非扩张性运营势头主导。总而言之,MedMen 是一家成立于 2010 年的美国大麻零售商,总部位于洛杉矶,以其高端药房品牌而闻名,但目前最好通过其治理、报告和监管逆风而非增长指标或市场份额领先地位来理解。